Date | Time | Source | Headline | Symbol | Company |
05/17/2024 | 4:57PM | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:45PM | Edgar (US Regulatory) | Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:41PM | Edgar (US Regulatory) | Form POSASR - Post-effective Amendment to an automatic shelf registration statement | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:32PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:31PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:28PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:28PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:27PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:27PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:23PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:23PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:22PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:21PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:21PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:20PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:19PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:18PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:18PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:16PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:15PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:LH | Laboratory Corporation of America Holdings |
05/17/2024 | 4:10PM | Edgar (US Regulatory) | Form 8-K12B - Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b) | NYSE:LH | Laboratory Corporation of America Holdings |
05/16/2024 | 4:19PM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:LH | Laboratory Corporation of America Holdings |
05/16/2024 | 8:02AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LH | Laboratory Corporation of America Holdings |
05/15/2024 | 8:00AM | PR Newswire (US) | Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy | NYSE:LH | Laboratory Corporation of America Holdings |
05/14/2024 | 12:40PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:LH | Laboratory Corporation of America Holdings |
05/08/2024 | 8:08AM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:LH | Laboratory Corporation of America Holdings |
05/08/2024 | 6:59AM | PR Newswire (US) | Labcorp to Webcast Its Annual Meeting of Shareholders | NYSE:LH | Laboratory Corporation of America Holdings |
05/07/2024 | 4:05PM | PR Newswire (US) | Invitae Receives Court Approval for Sale to Labcorp | NYSE:LH | Laboratory Corporation of America Holdings |
05/06/2024 | 4:40PM | Edgar (US Regulatory) | Form PX14A6G - Notice of exempt solicitation submitted by non-management | NYSE:LH | Laboratory Corporation of America Holdings |
04/29/2024 | 7:00AM | PR Newswire (US) | Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B | NYSE:LH | Laboratory Corporation of America Holdings |